Unequal tissue expression of proteins from the PA/PAI system, myoma necrosis, and uterus survival after uterine artery occlusion

被引：13

作者：

Cheng, Zhongping ^{[1
]}

Xie, Yan ^{[1
]}

Dai, Hong ^{[1
]}

Hu, Liping ^{[1
]}

Zhu, Yu ^{[1
]}

Gong, Jun ^{[1
]}

机构：

[1] Yangpu Dist Cent Hosp, Dept Obstet & Gynecol, Shanghai 200090, Peoples R China

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS | 2008年 / 102卷 / 01期

关键词：

myoma; plasminogen activator; inhibitor type 1; tissue plasminogen activator; urokinase plasminogen activator; uterine artery occlusion;

D O I：

10.1016/j.ijgo.2008.02.006

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Objective: To further the understanding of the mechanism behind myoma necrosis and uterus survival after uterine artery occlusion. Method: Myomal. and myometrial gene transcription and protein expression of tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), and plasminogen activator inhibitor type 1 (PAI-1) were investigated in 30 uteri. Results: Compared with myometrial expression, myomal expression was Less for uPA mRNA (1.34% +/- 2.18% vs 2.84% +/- 2.97%; P<0.05) and greater for PAI-1 mRNA (2.67% +/- 1.82% vs 1.27% +/- 1.99%; P<0.05), but the difference in tPA mRNA expression was not significant. Accordingly, compared with myometrial expression, myomal expression was less for the uPA protein (P<0.05) and greater for the PAI-1 protein (P<0.05), but the difference in tPA protein was not significant. Conclusion: The PA/PAI system was found to be expressed differently in myomas and the myometrium, which may play a rote in uterus survival and myoma necrosis after uterine artery occlusion. (C) 2008 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

引用

页码：55 / 59

页数：5

共 15 条

[1]

Blasi F, 1999, THROMB HAEMOSTASIS, V82, P298

[2] Future directions in myoma research [J].

Brahma, PK ;

Martel, KM ;

Christman, GM .

OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2006, 33 (01) :199-+

[3] Childbirth and myoma treatment by uterine artery occlusion: Do they share a common biology? [J].

Burbank, F .

JOURNAL OF THE AMERICAN ASSOCIATION OF GYNECOLOGIC LAPAROSCOPISTS, 2004, 11 (02) :138-152

[4]

Burbank F., 2000, J Am Assoc Gynecologic Laparoscop, V7, pS1, DOI DOI 10.1016/S1074-3804(05)60633-0

[5] Plasminogen activation and cancer [J].

Dano, K ;

Behrendt, N ;

Hoyer-Hansen, G ;

Johnsen, M ;

Lund, LR ;

Ploug, M ;

Romer, J .

THROMBOSIS AND HAEMOSTASIS, 2005, 93 (04) :676-681

[6] Traditional surgical approaches to uterine fibroids: Abdominal myomectomy and hysterectomy [J].

Guarnaccia, MM ;

Rein, MS .

CLINICAL OBSTETRICS AND GYNECOLOGY, 2001, 44 (02) :385-400

[7] Laparoscopic occlusion of uterine vessels for the treatment of symptomatic fibroids: Initial experience and comparison to uterine artery embolization [J].

Hald, K ;

Langebrekke, A ;

Klow, NE ;

Noreng, HJ ;

Berge, AB ;

Istre, O .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (01) :37-43

[8] Complications and myoma recurrence after laparoscopic uterine artery occlusion for symptomatic myomas [J].

Holub, Z ;

Eim, J ;

Jabor, A ;

Hendl, A ;

Lukac, J ;

Kliment, L .

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2006, 32 (01) :55-62

[9]

KOHIER HP, 2000, NEW ENGL J MED, V342, P1792

[10] Laparoscopic uterine artery occlusion for symptomatic leiomyomas [J].

Lichtinger, M ;

Hallson, L ;

Calvo, P ;

Adeboyejo, G .

JOURNAL OF THE AMERICAN ASSOCIATION OF GYNECOLOGIC LAPAROSCOPISTS, 2002, 9 (02) :191-198

← 1 2 →